Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dentsply Sirona (XRAY) EBITDA (2016 - 2025)

Historic EBITDA for Dentsply Sirona (XRAY) over the last 17 years, with Q3 2025 value amounting to -$218.0 million.

  • Dentsply Sirona's EBITDA rose 5281.39% to -$218.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$792.0 million, marking a year-over-year decrease of 16666.67%. This contributed to the annual value of -$879.0 million for FY2024, which is 93411.76% down from last year.
  • As of Q3 2025, Dentsply Sirona's EBITDA stood at -$218.0 million, which was up 5281.39% from -$128.0 million recorded in Q2 2025.
  • Dentsply Sirona's EBITDA's 5-year high stood at $172.0 million during Q4 2021, with a 5-year trough of -$1.2 billion in Q3 2022.
  • Over the past 5 years, Dentsply Sirona's median EBITDA value was $63.0 million (recorded in 2025), while the average stood at -$82.9 million.
  • As far as peak fluctuations go, Dentsply Sirona's EBITDA crashed by 102272.73% in 2022, and later soared by 220000.0% in 2024.
  • Dentsply Sirona's EBITDA (Quarter) stood at $172.0 million in 2021, then crashed by 62.21% to $65.0 million in 2022, then grew by 12.31% to $73.0 million in 2023, then tumbled by 797.26% to -$509.0 million in 2024, then soared by 57.17% to -$218.0 million in 2025.
  • Its EBITDA stands at -$218.0 million for Q3 2025, versus -$128.0 million for Q2 2025 and $63.0 million for Q1 2025.